Dr Reddy’s Laboratories: Global pharmaceutical company, India
What We Are
Our Vision & Values
The Management and Board
Corporate Governance
Sustainability
Executive Speeches/Articles
Key Milestones
Global Presence
Contact Us
  Quick Links
   Newsroom
   Global Presence
   Shareholder's Information
   Join Dr. Reddy’s
Did you know?
Dr. Reddy’s became the first Indian pharmaceutical company to out-license an original molecule when it out-licenced its anti-diabetic molecule, DRF 2593 (Balaglitazone), to Novo Nordisk in 1997.
 
Achieving and
                  going beyond
  Key Milestones

Tips:

1. Select a country of your choice.
2. Click to see our local contact details in that particular country.
Designed by
© 2001 - 2008 Dr. Reddy's Laboratories Ltd. All rights reserved
Site best viewed at 800x600 resolution